Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Angiogenesis. 2020 Aug 11;23(4):685–698. doi: 10.1007/s10456-020-09740-y

Fig. 8. Inhibition of Src or Rac1 inhibits VEGF-mediated CEC migration and tube formation.

Fig. 8.

a. CEC migration and b. tube formation were performed in CECs incubated with Src inhibitor, Saracatinib (10 nM), or/and Rac1 inhibitor (50 μM) in the presence or absence of VEGF (25 ng/ml) overnight (*p<0.05, **p<0.01 vs. PBS of Control; p=0.06, †p<0.05, ††p<0.01, and †††p<0.001 vs. VEGF of Control; #p<0.05 vs. PBS of Rac1 inhibitor and $ $p<0.01 vs. VEGF of Rac1 inhibitor; n=6–9 from two individual experiments).